Trial intelligence / Profile preview

Chloral hydrate syrup formulation effectiveness for sedation in children undergoing diagnostic procedures

IRCT20240630062282N1Phase 3Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of chloral hydrate in procedural sedation and analgesia (PSA) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Effective time of the drug, Sleep duration and 6 more. Started Aug 2024; status: completed.

02

Drugs

chloral hydrate
03

Conditions

procedural sedation and analgesia (PSA)

Beyond the preview

Go deeper on IRCT20240630062282N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240630062282N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call